These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24457096)

  • 1. Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients.
    Frisaldi E; Carlino E; Lanotte M; Lopiano L; Benedetti F
    Cortex; 2014 Nov; 60():3-9. PubMed ID: 24457096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response.
    Benedetti F; Lanotte M; Colloca L; Ducati A; Zibetti M; Lopiano L
    J Physiol; 2009 Aug; 587(Pt 15):3869-83. PubMed ID: 19546163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subthalamic nucleus and the placebo effect in Parkinson's disease.
    Frisaldi E; Zamfira DA; Benedetti F
    Handb Clin Neurol; 2021; 180():433-444. PubMed ID: 34225946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
    Maltête D; Jodoin N; Karachi C; Houeto JL; Navarro S; Cornu P; Agid Y; Welter ML
    J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Placebo effect in Parkinson's disease].
    Miwa H
    No To Shinkei; 2007 Feb; 59(2):139-46. PubMed ID: 17315755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease.
    Kane A; Hutchison WD; Hodaie M; Lozano AM; Dostrovsky JO
    Neuroreport; 2009 Nov; 20(17):1549-53. PubMed ID: 19829159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teaching neurons to respond to placebos.
    Benedetti F; Frisaldi E; Carlino E; Giudetti L; Pampallona A; Zibetti M; Lanotte M; Lopiano L
    J Physiol; 2016 Oct; 594(19):5647-60. PubMed ID: 26861164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus functional organization revealed by parkinsonian neuronal oscillations and synchrony.
    Moran A; Bergman H; Israel Z; Bar-Gad I
    Brain; 2008 Dec; 131(Pt 12):3395-409. PubMed ID: 18986993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of tremor circuits in parkinsonian and essential tremor.
    Cagnan H; Little S; Foltynie T; Limousin P; Zrinzo L; Hariz M; Cheeran B; Fitzgerald J; Green AL; Aziz T; Brown P
    Brain; 2014 Dec; 137(Pt 12):3223-34. PubMed ID: 25200741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular principles underlying normal and pathological activity in the subthalamic nucleus.
    Bevan MD; Atherton JF; Baufreton J
    Curr Opin Neurobiol; 2006 Dec; 16(6):621-8. PubMed ID: 17084618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Emotion and basal ganglia (II): what can we learn from subthalamic nucleus deep brain stimulation in Parkinson's disease?].
    Péron J; Dondaine T
    Rev Neurol (Paris); 2012; 168(8-9):642-8. PubMed ID: 22901366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of electrical stimulation of the parafascicular nucleus on the neuronal activities of the subthalamic nucleus and the ventromedial nucleus in rats].
    Lin FK; Xin Y; Gao DM; Xiong Z; Chen JG
    Sheng Li Xue Bao; 2007 Feb; 59(1):79-85. PubMed ID: 17294046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation promotes excitation and inhibition in subthalamic nucleus in Parkinson's disease.
    Galati S; Scarnati E; Mazzone P; Stanzione P; Stefani A
    Neuroreport; 2008 Apr; 19(6):661-6. PubMed ID: 18382282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial extent of β oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients.
    Alavi M; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
    Exp Neurol; 2013 Jul; 245():60-71. PubMed ID: 23063495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
    Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
    Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.
    Benedetti F; Colloca L; Torre E; Lanotte M; Melcarne A; Pesare M; Bergamasco B; Lopiano L
    Nat Neurosci; 2004 Jun; 7(6):587-8. PubMed ID: 15146189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.